As shown in Figure 2V−W, we found that the OS of blood cancer patients including B‐Cell Lymphoma and DLBCL in the WDR6 high‐expression group were significantly shorter than the low‐expression group. Here, WDR6 is linked to hematopoietic and lymphoid system neoplasm.